Axcella Financial Statements From 2010 to 2022

AXLA
 Stock
  

USD 1.83  0.09  4.69%   

Axcella Health financial statements provide useful quarterly and yearly information to potential Axcella Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Axcella Health financial statements helps investors assess Axcella Health's valuation, profitability, and current liquidity needs.
Axcella Health does not presently have any fundamental signals for analysis.
.
  
Check Axcella Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axcella main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Axcella financial statements analysis is a perfect complement when working with Axcella Health Valuation or Volatility modules. It can also supplement Axcella Health's financial leverage analysis and stock options assessment as well as various Axcella Health Technical models . Please continue to the analysis of Axcella Health Correlation against competitors.

Axcella EBITDA Analysis

Axcella Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current Axcella Health EBITDA

    
  (70.74 M)  
Most of Axcella Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axcella Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition

According to the company disclosure, Axcella Health reported earnings before interest,tax, depreciation and amortization of (70.74 Million). This is 108.06% lower than that of the Healthcare sector and 170.63% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 101.81% higher than that of the company.

Axcella Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Axcella Health's current stock value. Our valuation model uses many indicators to compare Axcella Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axcella Health competition to find correlations between indicators driving Axcella Health's intrinsic value. More Info.
Axcella Health is number one stock in return on asset category among related companies. It is number one stock in book value per share category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Axcella Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Axcella Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axcella Health's earnings, one of the primary drivers of an investment's value.

About Axcella Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Axcella Health income statement, its balance sheet, and the statement of cash flows. Axcella Health investors use historical funamental indicators, such as Axcella Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Axcella Health investors may use each financial statement separately, they are all related. The changes in Axcella Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axcella Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Axcella Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Axcella Health. Please read more on our technical analysis and fundamental analysis pages.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Axcella Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Module

Pair Trading with Axcella Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axcella Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axcella Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axcella Health

The ability to find closely correlated positions to Axcella Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axcella Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axcella Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axcella Health to buy it.
The correlation of Axcella Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axcella Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axcella Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axcella Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Axcella Health Correlation against competitors. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.